hero section gradient
15 handpicked stocks

Supply Chain Reshoring Investment Theme Explained

In response to Chinese export controls, the US announced a 100% tariff on all Chinese imports, escalating the trade war. This creates a potential investment opportunity in American companies poised to benefit from the reshoring of manufacturing and supply chains.

Author avatar

Han Tan | Market Analyst

Published on October 11

Your Basket's Financial Footprint

Interpretation of basket market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance suggests generally lower volatility and returns that tend to track broad market performance.
  • Consider this basket a potential core holding for diversification, not a speculative growth play.
  • Likely to offer steady, long-term appreciation rather than rapid, short-term gains.
Total Market Cap
  • PLXS: $3.61B

  • FLEX: $21.16B

  • JBL: $20.82B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The 100% tariff on Chinese imports creates a powerful economic incentive for companies to relocate manufacturing back to the United States. This reshoring trend could drive sustained growth in domestic industrial, logistics, and manufacturing firms that support this supply chain realignment.

2

What You Need to Know

This group focuses on American companies positioned to benefit from the strategic relocation of manufacturing and supply chains. These firms include domestic electronics manufacturing services, industrial equipment producers, and logistics companies that form the backbone of revitalised US production.

3

Why These Stocks

Each company in this group has been handpicked by professional analysts for their direct positioning to facilitate and benefit from supply chain realignment. They represent targeted opportunities to capitalise on this significant geopolitical and economic catalyst.

Why You'll Want to Watch These Stocks

🏭

Manufacturing Renaissance

The 100% tariff creates unprecedented incentives for companies to bring production home. American manufacturers could see a surge in demand as businesses scramble to avoid crushing import duties.

First-Mover Advantage

Companies already positioned in domestic manufacturing and logistics are perfectly placed to capitalise on this supply chain shift. Early investors could benefit from this structural change before it becomes mainstream.

🎯

Expert-Selected Opportunities

These aren't random picks - each company has been carefully chosen by professional analysts for their direct exposure to reshoring trends. This targeted approach focuses on firms most likely to benefit from the trade war catalyst.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.

Cargo Capacity Crisis: Which Stocks May Benefit Most?

Cargo Capacity Crisis: Which Stocks May Benefit Most?

The crash of a UPS cargo plane has led to the grounding of an entire class of aging aircraft across the logistics industry. This creates a potential investment opportunity in competing cargo carriers and aircraft manufacturers poised to fill the resulting gap in shipping capacity.

UK-US Pharma Trade Deal | Tariff-Free Market Access

UK-US Pharma Trade Deal | Tariff-Free Market Access

A new trade deal eliminates tariffs on pharmaceuticals between the UK and the US, strengthening transatlantic trade. This creates a powerful tailwind for pharmaceutical companies in both countries, potentially boosting exports, innovation, and profitability.

Frequently Asked Questions